Design and Optimization of Dual-Drug Nanocarriers for Targeted Management of Diabetic Neuropathy (Pregabalin + Alpha-Lipoic Acid): A Quality by Design Approach. VER [Internet]. 2025 Dec. 9 [cited 2026 Aug. 29];8(19s):18-29. Available from: https://verjournal.com/index.php/ver/article/view/1406